Modi Ventures

Thanks to the editors at Nature Portfolio #NatureBiotechnology for highlighting Unnatural Products Inc. and the work we're doing in the oral macrocyclic peptide space and Michael Eisenstein for the great write up! https://lnkd.in/gh4kBq4X

Modi Ventures was identified as a 2023 Med Device Most Active Investor in the US and Europe by HSBC Innovation Banking. Modi Ventures (#LSIEurope24 Investor) invests in funds and companies at the intersection of technology and biology. Launched in 2023, they have invested in 16 startups and 11 funds. They make early-stage investments in technology platforms that have a positive impact on health. This includes a deep focus on opportunities that leverage AI, microfluidics (hardware), multiomics, precision medicine, synbio, gene editing, and living therapies. Their portfolio includes companies like: • Starling (YC W22) (Hannah McKenney) • Perceptive Technologies (Dr. Christopher J. Ciriello) • Lapsi Health (Jhonatan Bringas Dimitriades, MD - #LSIAlumni) • among others Their portfolio also includes funds like: • Khosla Ventures • First Spark Ventures • ARTIS Ventures • among others We’re thrilled to welcome Founder and General Partner, Sahirzeeshan (Sahir) Ali at Modi Ventures to LSI Europe ‘24 this September 16-20th in Sintra, Portugal. Want to see what other investors are joining us at LSI Europe ‘24? Head over to our website to see a preview of 100+ VCs who are confirmed to attend.

Woot woot! Tiny Health is in Times Square, NYC! Seeing Tiny Health featured on these iconic big screens is a surreal moment that fills my heart with immense pride and gratitude. When we launched our microbiome platform just two years ago after two intense years of R&D, I could not have anticipated that we’d be celebrating this moment today, with the honor of serving almost 30,000 families, helping them take proactive steps toward better lifelong health and often transforming their lives for the better. “If it weren’t for Tiny Health, I might still be struggling to reintroduce foods into my diet and still needing to take shifts with my partner to hold my baby while she sleeps! She is now a great sleeper. I am incredibly grateful that I found your team when I did as we had exhausted every other possibility.” (read full story here https://bit.ly/thsleep) It's for stories like these that our mission-driven team works so hard to make our microbiome platform truly the best-in-class for families and any individual looking to heal from chronic conditions, optimize their health span and increase longevity! To our Tiny family and supporters - your trust and belief in Tiny Health have been the driving force behind our success in making a meaningful impact on the lives of families. If you’re in the Big Apple, stop by 47th St and 7th Ave and come see us on the big screen! 🗽🌃 https://lnkd.in/g2VDwXgH A special thank you to Brex for believing in our vision and getting us featured - truly a dream! #guthealth #gutmicrobiome #timesquare #billboard #nyc #first1000days #GrowWithBrex #startup #femalefounder

🎉 Celebrating One Year of Modi Ventures This March, we celebrated our first anniversary, and last week, we hosted our annual reception at the Helix Park TMC3 building in #Houston. We are thrilled to call this hub of innovation our new home. Our neighbors include Texas Medical Center Ventures, the Jim Allison Institute, and pioneers from UT and A&M in genomic research and portal innovations venture. A heartfelt thank you to William McKeon, President of Texas Medical Center, and Andrew Yang for his support from the very beginning. Our journey has deepened our understanding of the biology stack essential for human life and health, from single cell to precision medicine. We are strategically deploying our efforts across diverse sectors, funding innovation at every level of the biological and health stack. 𝐁𝐢𝐨𝐥𝐨𝐠𝐢𝐜𝐚𝐥 𝐋𝐚𝐲𝐞𝐫𝐬 : Next Gen Protein Sequencing (Glyphic Biotechnologies), #Generative Biology and Medicine (Generate:Biomedicines, Atomic AI Unnatural Products Inc.), SynBio (Aether, General Proximity), Cell and Gene Therapy (Latus Bio), Cancer Detection (Harbinger Health) and more. 𝐈𝐧𝐧𝐨𝐯𝐚𝐭𝐢𝐨𝐧 𝐒𝐞𝐜𝐭𝐨𝐫𝐬: From Microbiome (Tiny Health) to Robotics (Perceptive Technologies), and Digital Health (Ozlo Sleep, Lapsi Health, Elemind Technologies, Inc.) and Longevity (Rubedo Life Sciences) 𝐒𝐭𝐫𝐚𝐭𝐞𝐠𝐢𝐜 𝐏𝐚𝐫𝐭𝐧𝐞𝐫𝐬𝐡𝐢𝐩𝐬 (𝐋𝐢𝐦𝐢𝐭𝐞𝐝 𝐏𝐚𝐫𝐭𝐧𝐞𝐫): We've partnered with leading funds and visionaries like Abingworth, ARTIS Ventures, S32 (Section32), First Spark Ventures, Tim Draper (Draper Associates), and Vinod Khosla (Khosla Ventures), Reed Jobs (Yosemite), Michael Langer/Bob Langer and Antler covering areas from Life Sciences to Oncology and Digital Health. We are also proud to back two awesome female GPs Suzanne Rombeau Fletcher (Zelda VC) and Katie Jacobs Stanton (Moxxie Ventures) Special thanks to Jimmy Ku, Junaid Bajwa, Ben Rosenbluth, Todd Ruppert and to my team for their significant contributions to Modi Ventures. Thank you to Linda Avey, Lynda Chin, Raphael Townshend and Joshua Yang for speaking at the reception. Stay tuned for a detailed post where I'll dive deeper into funding environment and the exciting convergence of technology and biomedicine. Here's to many more years of innovation and success! 🚀

Join us in welcoming the 2024 MedTech Innovator cohort featuring 65 medtech and digital health startups revolutionizing healthcare! 👏 This cohort represents a diverse array of talents, ideas, and perspectives coming together with the common goal of driving meaningful change. We look forward to the accelerator ahead and partnering with our ecosystem to provide the 2024 cohort with mentorship, strategic planning, visibility, and more. Learn more about their groundbreaking tech and the official press release here 👉 : https://lnkd.in/eq8zbHmR #medtech #medicaldevice #tech #digitalhealth #mti #cohort #strategics

We’re thrilled to have been named to the 2024 CNBC Disruptor 50 list, ranking at #25. Every year, CNBC recognizes companies that are disrupting the status quo, transforming industries and addressing some of society’s biggest challenges. This recognition underscores our commitment to generating optimal therapeutics for the greatest impact on human health. Alongside industry innovators like OpenAI and ElevateBio, we are proud to be recognized for our pioneering efforts in shaping the future of medicine and creating solutions that address critical health challenges worldwide. Learn more about our recognition: https://lnkd.in/dDm6hpXQ   #GenerativeAI | #Disruptor50